ARTICLE | Clinical News
Alisporivir: Phase I started
September 1, 2014 7:00 AM UTC
Novartis began an open-label Phase I trial evaluating alisporivir in combination with EDP-239 in about 42 healthy volunteers. EDP-239, an HCV NS5A protein inhibitor, is in Phase I testing to treat H...